PME Pro Medicus Ltd
- 113.520
- +1.420+1.27%
Pro Medicus Ltd News
Macquarie Australia Conference Unlikely to Be 'Downgrade Conference' -- Market Talk
0124 GMT - The coming annual Macquarie Australia Conference is unlikely to be a "downgrade conference,"with an improving earnings backdrop set to provide a net positive surprise for this year, say Mac
Goldman Sachs Just Slapped a Buy Rating on This ASX 200 Tech Stock
Pro Medicus Limited (ASX: PME) shares have been among the best performers on the ASX 200 index over the last 12 months.
Top Brokers Name 3 ASX Shares to Buy Today 17 April 2024
Many of Australia's top brokers have been busy adjusting their financial models again. This has led to the release of a number of broker notes this week.
Imaging Tech Provider Pro Medicus Gets New Bull -- Market Talk
0238 GMT - Pro Medicus gets a new bull at Goldman Sachs, where analysts reckon that the healthcare-imaging software provider is a clear incumbent technology leader. Initiating coverage of the Australi
Pro Medicus Started at Buy by Goldman Sachs >PME.AU
Pro Medicus Started at Buy by Goldman Sachs >PME.AU
Pro Medicus' (ASX:PME) 45% CAGR Outpaced the Company's Earnings Growth Over the Same Five-year Period
AU Evening Wrap: Australian Shares Rise 0.5% Amid Real Estate Gains
Ten of eleven sectors finished higher, as the benchmark index rebounded from Friday's 0.15% slip.
2 ASX 200 Shares to Buy in the Most 'Interesting' Sector Right Now
With the S&P/ASX 200 Index (ASX: XJO) rocketing 13.7% since the start of November, investors need to be careful they don't buy stocks that are overvalued.
Top Brokers Name 3 ASX Shares to Buy Next Week 3 March 2024
Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these ASX shares are in the buy zone
Leading Brokers Name 3 ASX Shares to Buy Today 26 February 2024
With so many shares to choose from on the ASX, it can be difficult to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.
Why Are ASX Tech Shares Booming on Friday?
It's been a fairly lucrative day for the S&P/ASX 200 Index (ASX: XJO) and most ASX shares so far this Friday.
Top Brokers Name 3 ASX Shares to Buy Next Week 18 February 2024
It was another busy week for Australia's top brokers. This led to the release of a large number of broker notes.
Pro Medicus Downgraded to Sell From Hold by Bell Potter
Pro Medicus Downgraded to Sell From Hold by Bell Potter
Pro Medicus Price Target Raised 15% to A$93.00/Share by Wilsons
Pro Medicus Price Target Raised 15% to A$93.00/Share by Wilsons
Pro Medicus' Net Profit, Revenue Jumps in Fiscal H1
Pro Medicus' (ASX:PME) net profit jumped 33% to AU$36.3 million in the fiscal first half ended Dec. 31, 2023, from AU$27.2 million in the same half-year period a year prior. EPS rose to AU$0.3461 from
Pro Medicus's Pipeline Is Strong Across All Market Sectors, CEO Says>PME.AU
Pro Medicus's Pipeline Is Strong Across All Market Sectors, CEO Says>PME.AU
Pro Medicus Aiming to Build Presence in North America, Germany, Australia>PME.AU
Pro Medicus Aiming to Build Presence in North America, Germany, Australia>PME.AU
Pro Medicus 1H Net A$36.25M Vs. Net A$27.2M >PME.AU
Pro Medicus 1H Net A$36.25M Vs. Net A$27.2M >PME.AU
Pro Medicus Gets New Bull on U.S. Prospects -- Market Talk
0018 GMT - Pro Medicus gets a new bull at Macquarie, where analysts see the healthcare imaging software provider increasing its share of the U.S. market to 25% by FY 2035. The analysts tell clients in
Pro Medicus Started With A$120.00/Share Target Price by Macquarie>PME.AU
Pro Medicus Started With A$120.00/Share Target Price by Macquarie>PME.AU
Analysis
Price Target
No Data
